Table 7.
Criterion variables #3 and #4
| Total | Patients with follow-up data | Patients without follow-up data | Wilcoxon P-value | |
|---|---|---|---|---|
|
N (%) Mean (SD) N = 96 |
N (%) Mean (SD) N = 58 |
N (%) Mean (SD) N = 38 |
||
| Overall, during the last 6 months, how would you rate the severity of your Parkinson’s disease symptoms? | ||||
| No symptoms | 1 (1.0) | 1 (1.7) | 0 (0.0) | 0.13 |
| Mild symptoms | 39 (40.6) | 27 (46.6) | 12 (31.6) | |
| Moderate symptoms | 45 (46.9) | 24 (41.4) | 21 (55.3) | |
| Severe symptoms | 11 (11.5) | 6 (10.3) | 5 (13.2) | |
| PHQ-9 categories for planning and monitoring treatment | ||||
| May not need depression treatment (scores: 0–4) | 37 (38.9) | 25 (43.9) | 12 (31.6) | 0.11 |
| Based on clinical judgment about treatment on duration of symptoms and functional impairment (scores: 5–14) | 47 (49.5) | 28 (49.1) | 19 (50.0) | |
| Warrants treatment for depression using antidepressant, psychotherapy, and/or a combination treatment approach (scores: 15–27) | 11 (11.6) | 4 (7.0) | 7 (18.4) | |